Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer
Clinical trial NCT06015724 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06015724
- Sponsor
- Georgetown University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-31
- Primary completion
- 2027-06-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.